Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/1999
09/01/1999CN1227611A Isolated nucleic acid molecules which are members of the MAGE-B family and use thereof
09/01/1999CN1227610A Antibodies against a complex of CD4 and a chemokine receptor domain, and their use against HIV infections
09/01/1999CN1227609A Method for producing carotenoid compounds and speciality oils in plant seeds
09/01/1999CN1227608A Transcriptional silencing elements and their binding factors
09/01/1999CN1227607A Humanized immunoglobulin reactive with alpha 4 beta 7 integrin
09/01/1999CN1227606A Purified proteins, recombinant DNA sequences and processes for controlling the ripening of coffee plants
09/01/1999CN1227605A Plant retinoblastoma-associated proteins
09/01/1999CN1227604A Multivarient IL-3 hematopoiesis fusion protein
09/01/1999CN1227603A TIE-2 receptor ligands (TIE ligand-3; TIE ligand-4) and their uses
09/01/1999CN1227602A Tumor antigen proteins, genes thereof and tumor antigen peptides
09/01/1999CN1227567A Exendin analogues, processes for their preparation and medicaments containing them
09/01/1999CN1227565A Viral peptides with structural homology to protein G of respiratory syncytial virus
09/01/1999CN1227497A Purified sperm surface antigen, monoclonal antibody therefor and application therefor
09/01/1999CN1227496A Screening method for compounds useful in the regulation of body weight
09/01/1999CN1227494A Therapeutic applications of T-BAM (CD40L) technology to treat diseases involving smooth muscle cell
09/01/1999CN1227264A Method of producing L-serine by fermentation
09/01/1999CN1044919C Particle-mediated transformation of soybean plants and lines
09/01/1999CN1044911C Method for preparing prodrug
08/1999
08/31/1999US5945675 Methods of screening for a tumor or tumor progression to the metastatic state
08/31/1999US5945589 Derivatives of Bauhinia purpurea lectin and their use as larvicides
08/31/1999US5945585 Specific for palmitoyl, stearoyl and oleoyl-alp thioesters nucleic acid fragments encoding acyl-acp thiosesterase enzymes and the use of these fragments in altering plant oil composition
08/31/1999US5945581 Implanting disease resistance to plants with viral replicase DNA molecules which do not have a read-through portion
08/31/1999US5945580 Capsicum hemicellulase polynucleotides and polypeptides
08/31/1999US5945579 Modification of crop plant architecture to enhance yield by causing proximity-conditional dwarfing to control shade avoidance reactions
08/31/1999US5945577 Nuclear transfer units for cells
08/31/1999US5945525 Mixing composite particle of superparamagnetic oxide and fine silica with polynucleotide solution and chaotropic agent, separating particle from solution using magnetic field, eluting polynucleotide from carrier
08/31/1999US5945524 Nucleoside with dansylethoxycarbonyl group as base-labile 5'-hydroxyl protective group; for efficient synthesis
08/31/1999US5945523 Tyrosine kinase protein
08/31/1999US5945521 Preparation of phosphorothioate oligomers
08/31/1999US5945515 Product and process for isolating DNA, RNA and proteins
08/31/1999US5945513 A human t-cell antigen and ligand for cd40 receptor; for promoting b cell proliferation, immunosuppressant for transplants, therapy for autoimmune diseases, human immunodeficiency virus and antitumor agents
08/31/1999US5945511 Class II cytokine receptor
08/31/1999US5945510 Substantially pure zonulin, a physiological modulator of mammalian tight junctions
08/31/1999US5945509 A polypeptide that codes for a membrane protein involved in neurotransmission; therapy and diagnosis of nervous systemdisorders
08/31/1999US5945506 Nucleotide sequence
08/31/1999US5945505 Human phospholemman-like protein
08/31/1999US5945403 Angiostatin fragments and method of use
08/31/1999US5945401 Polypeptides as antidiabetic agents
08/31/1999US5945400 Nucleic acid-containing composition, preparation and use thereof
08/31/1999US5945397 A soluble protein capable binding tumor necrosis factor for use in raising antibodies, in diagnosis and therapy, regulating the immune activities of cytokine
08/31/1999US5945336 Oligonucleotide up to 35 nucleotides in length with at least 18 contiguous nucleotides complementary to specific nucleotide sequence; for suppression of interleukin-6 receptors; anticarcinogenic agents; viricides
08/31/1999US5945335 A nucleic acid molecule that functions as an accessory molecule for recombinant adeno-associated virus particle production; gene therapy for diabetes and hemophilia and anticarcinogenic agent
08/31/1999US5945334 Apparatus for packaging a chip
08/31/1999US5945330 Polynucleotide
08/31/1999US5945329 Mutant carboxypeptidase y with modified active sites able to catalyze tranacylation of preselected peptide substrate with preselected nucleophile; for post-translational modification of recombinant peptides
08/31/1999US5945326 Culturing transformed vector; gene expression, genetic engineering
08/31/1999US5945325 Mutant enzyme with specific amino acid substitutions isolated from library; for deblocking, deprotecting beta-lactam antibiotics
08/31/1999US5945324 A cdna molecule; for identifying new fungicide compounds
08/31/1999US5945323 DNA encoding a 2-acyltransferases
08/31/1999US5945322 Several open reading frames from neisseria gonorrhoeae; for diagnosis and bactericides; for probes and primers
08/31/1999US5945320 A dna molecule that codes a protein; for screening of new antibiotics
08/31/1999US5945314 Process for synthesizing oligosaccharides
08/31/1999US5945310 DNA encoding members of the IL-1 family, IL-1 delta
08/31/1999US5945308 Polynucleotide
08/31/1999US5945307 Nucleotide sequences that code a protein expressed in the brain and belonging to the 5-hydroxytryptamine receptor family; gene therapy, screening of drugs and genetic disorders, diagnostic assays
08/31/1999US5945305 Polynucleotides for diagnosing congenital heart disease resulting from down syndrome
08/31/1999US5945304 Producing recombinant polypeptides by transfecting escherichia, controlling expression of target polypeptides using osmotic promoters; producing acetylcholinesterase, superoxide dismutases, growth hormones and hepatitis antigen
08/31/1999US5945303 Isolated nucleic acid encoding human humatopoietic-specific protein for use in treating autoimmune disorder, graft rejection, antitumor agent, viral infection, fungal and bacteria infection
08/31/1999US5945302 Nucleotide sequences that code for proteins for use in recombinant technology, induce production of cytokines, activate cell differentiation, stimulate and suppress immune responses, and therapy for autoimmune diseases
08/31/1999US5945300 Polypeptides with dna(rna) encoding and genetic engineering
08/31/1999US5945294 Method to detect IgE
08/31/1999US5945292 Method of identifying cells with polypeptide surface marker
08/31/1999US5945290 Antisense modulation of RhoA expression
08/31/1999US5945288 Method for cloning and producing the PmeI restriction endonuclease
08/31/1999US5945285 Vibrio cholerae having increased sensitivity to antibiotics
08/31/1999US5945284 Length determination of nucleic acid repeat sequences by discontinuous primer extension
08/31/1999US5945283 Methods and kits for nucleic acid analysis using fluorescence resonance energy transfer
08/31/1999US5945282 Nucleic acid probes from prokaryotic microoganism not including the transfer rna gene for diagnosis of neisseria, haemophilus, branhamella, bordetella, streptococcus, camphylobactter infections
08/31/1999US5945279 Screening system for identifying compounds that regulate steroid and orphan receptors mediation of DNA transcription
08/31/1999US5945278 Bacteria genetically engineered to produce greater than wild-type amounts of prsa protein involved in protein secretion; for enhanced secretion of hyperexpressed homologous and heterologous proteins
08/31/1999US5945277 Determining the presence of four corners virus in a sample by reverse transcribing viral rna then amplifying the dna using primers, the detected amplified product indicates the presence of adult respiratory distess syndrome
08/31/1999US5945276 Cells carry an integrated plasmid containing a reporter gene linked to a cytomegalovirus promoter that detects cytomegalo virus without detecting herpes simplex virus-1; comparing level of expression of reporter gene to a predetermined level
08/31/1999US5945274 Quantitative analysis of free lysylpyridinoline in a urine sample and correlating it to bone resorption in vivo wherein urine sample is hydrolyzed
08/31/1999US5945273 Human oxalyl-coa decarboxylase
08/31/1999US5945096 Administering to the human for suppressing a human immune response to an antigen, an effective amount of antigen non-specific human glycosylation inhibiting factor
08/31/1999US5944971 Large scale DNA microsequencing device
08/31/1999US5944803 Isolatable multi-point serial communication utilizing a single universal asynchronous receiver and transmitter (UART)
08/31/1999US5944652 Method for breeding chickens
08/31/1999CA2218755C Monoclonal antibody to human beta 2 integrin alpha subunit
08/31/1999CA2192095C Method and apparatus for fabricating microarrays of biological samples
08/31/1999CA2165669C Fruit specific promoters
08/31/1999CA2163120C Method of controlling insects
08/31/1999CA2110988C Sequence-specific binding polymers for duplex nucleic acids
08/31/1999CA2078132C A process for distinguishing nucleic acids on the basis of nucleotide differences
08/31/1999CA2055542C Pichia pastoris acid phosphatase gene
08/31/1999CA2018345C Stabilization of carboxyl esterase
08/31/1999CA2012777C Process for isolating nucleic acid
08/31/1999CA2004364C Antisense oligonucleotides to c-myb oncogene and uses thereof
08/27/1999CA2263482A1 Method for marker-free repetitive dna expression cassette exchange in the genome of cells or parts of cells
08/26/1999WO1999042929A1 Molecular computing elements: gates and flip-flops
08/26/1999WO1999042839A2 Treating cancer
08/26/1999WO1999042837A1 Treating cancer
08/26/1999WO1999042836A1 Treating cancer
08/26/1999WO1999042835A1 Treating cancer
08/26/1999WO1999042834A2 Treating cancer
08/26/1999WO1999042832A1 Magnetic particle transfer device and method
08/26/1999WO1999042828A2 Treating cancer
08/26/1999WO1999042821A2 Treating cancer
08/26/1999WO1999042618A1 Quantitative determination of nucleic acid amplification products
08/26/1999WO1999042612A1 A fast and exhaustive method for selecting a prey polypeptide interacting with a bait polypeptide of interest: application to the construction of maps of interactors polypeptides